Navigation Links
CoolTouch Inc. Settles Diomed Lawsuit, Files Re-examination Request for Cynosure '873 Patent
Date:4/13/2009

ROSEVILLE, Calif., April 13 /PRNewswire/ -- On April 7, 2009, the Boston District Court dismissed the "Diomed" lawsuit between Endolaser Associates, LLC and CoolTouch Inc. after CoolTouch signed a settlement agreement with Dr. Luis Navarro. This patent infringement suit was originally filed in 2004 and relates to the use of lasers for endovenous ablation. CoolTouch will license the '777 Navarro patent and pay royalties on CTEV laser sales and accessories that potentially allow vein wall contact with the emitting part of the fiber.

CoolTouch CEO David R. Hennings states, "We have reached an agreement that recognizes the inventor's pioneering work in the field of endovenous laser ablation and makes business sense for CoolTouch."

In another patent matter, CoolTouch, working with the Boston law firm of McCarter & English LLP, has filed a re-examination request with the U.S. Patent Office of the '873 Paolini laser lipolysis patent assigned to Cynosure, which is the subject of litigation between the parties. CoolTouch requests the re-examination based on prior art by Dr. David Apfelberg and by Mr. David Hennings. CoolTouch has filed for a stay in the litigation until the patent office rules on the validity of this patent. Over 70% of re-examinations by the Patent Office result in claim rejections.

Until the stay is accepted, CoolTouch is confident that the court will also rule in its favor on the issue of non-infringement. On Dec. 22, 2008, the court's Markman ruling rejected Cynosure's attempts to define "adjacent" to mean "in the vicinity of" the tip of the needle. The court said that "adjacent" means "next to" the tip of the needle. The CoolTouch CoolLipo(TM) device uses a fiber that extends 5mm beyond the tip of the cannula and is clearly not "next to" the tip of the cannula.

Recently, the patent office has published two new CoolTouch patent applications that relate to laser-assisted lipolysis. These new patent applications are continuations-in-part of issued patent No. 7,217,265 filed in May 2005, and cover laser lipolysis devices such as thermal sensing, suction handpieces and placement of the fiber optic in direct contact with the tissue.

About CoolTouch

CoolTouch Inc. is a leading U.S.-based developer and manufacturer of innovative, advanced laser products for medical professionals. Engineering and science-based, CoolTouch is considered a pioneer in the medical and aesthetics technology industry. In 1994, CoolTouch introduced the first 1320 nm wavelength laser to medical professionals for non-ablative wrinkle treatment. CoolTouch continued to set new standards in the industry with the launch of CoolTouch CTEV in 2004 for varicose vein treatment and with CoolLipo for laser lipolysis and skin tightening in 2007. CoolTouch products are FDA-cleared and are manufactured in Roseville, Calif. For more information: www.cooltouch.com


'/>"/>
SOURCE CoolTouch Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
2. Cynosure Files Patent Infringement Lawsuit Against CoolTouch Inc.
3. CoolTouch Inc. Responds to Cynosure Patent Infringement Lawsuit
4. CoolTouch Introduces CoolBlue Duet(TM) Laser Lipolysis Suction Handpiece
5. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
6. CoolTouch Launches CoolLipo Trio Offering Physicians Three Functions in One
7. Cynosure Obtains Favorable Markman Rulings in Patent Infringement Case Against CoolTouch
8. Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB
9. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
10. Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter
11. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For the first time, International ... the exhibit floor for the 2017 HIMSS Conference & Exhibition at ... 2017, more than 40,000 healthcare industry professionals are expected at the conference, where ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's ... goals for each and every seminar, session and class she offers. At ... brainwave tools which help energize creativity, focus mental functions, enhance athletic focus and ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... named a finalist in the 8th Annual DecisionHealth Platinum Awards in recognition of ... Qualis Health’s work is recognized across multiple award categories, highlighting four of the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will ... Trinity Health and the U.S. Soccer Foundation announced today that they have awarded ... Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
(Date:2/16/2017)... REDWOOD CITY, Calif. , Feb. 16, 2017 ... ), a specialty pharmaceutical company focused on the ... treatment of moderate-to-severe acute pain, announced that ... executive officer and a member of the company,s ... Mr. Angotti brings over two decades of experience ...
(Date:2/16/2017)... 16, 2017 Research and Markets has announced ... Analysis & Trends - Function, Application, Cancer Type, Technology - Forecast ... ... Market is poised to grow at a CAGR of around 28.6% ... Some of the prominent trends that the ...
Breaking Medicine Technology: